Host: Jeffery D. Dunn, PharmD, MBA Guest: Gary M. Owens, MD Guest: Anita L. Nelson, MD Are you ready to see what is on the horizon to more effectively navigate vasomotor symptoms (VMS)? Join Drs. Dunn, Owens, and Nelson
Host: Marc P. Bonaca, MD, MPH This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER
Host: Daniel Gaudet, MD, PhD This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER P
Host: Manesh R. Patel, MD This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER PAD
Host: Marc P. Bonaca, MD, MPH This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER
Host: Manesh R. Patel, MD This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER PAD
Host: Tauseef Ali, MD, FACG, AGAF Host: Sabina Ali, MD Host: Neil Nandi, MD, FACP Host: Tina Aswani-Omprakash, MPH A South Asian pediatric gastroenterologist discusses the epidemiology of IBD, distinct phenotypes, the
Host: Tauseef Ali, MD, FACG, AGAF Host: Sabina Ali, MD Host: Neil Nandi, MD, FACP Host: Tina Aswani-Omprakash, MPH A South Asian pediatric gastroenterologist discusses the epidemiology of IBD, distinct phenotypes, the
Host: Anne Marie Morse, DO, FAASM One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencing sympt
Host: Kevin Trice, MD One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencing symptoms of OSA,
Host: Anne Marie Morse, DO, FAASM One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencing sympt
Host: Michael E. Yurcheshen, MD, FAASM One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencing
Host: Kevin Trice, MD One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencing symptoms of OSA,
Host: Michael E. Yurcheshen, MD, FAASM One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencing
Host: Seema Khosla, MD, FCCP, FAASM One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencing sym
Host: Alcibiades J. Rodriguez, MD, FAASM One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencin
Host: Seema Khosla, MD, FCCP, FAASM One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencing sym
Host: Alcibiades J. Rodriguez, MD, FAASM One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencin
Host: Michael A. Levine, MD, FAAP, MACE, FACP Host: B. Michelle Schweiger, DO, MPH Autosomal Dominant Hypocalcemia Type 1 (ADH1) is caused by gain-of-function variants of the CASR gene encoding the calcium-sensing receptor (Ca
Host: Michael A. Levine, MD, FAAP, MACE, FACP Host: B. Michelle Schweiger, DO, MPH Autosomal Dominant Hypocalcemia Type 1 (ADH1) is caused by gain-of-function variants of the CASR gene encoding the calcium-sensing receptor (Ca
Host: Michael A. Levine, MD, FAAP, MACE, FACP Host: B. Michelle Schweiger, DO, MPH Autosomal Dominant Hypocalcemia Type 1 (ADH1) is caused by gain-of-function variants of the CASR gene encoding the calcium-sensing receptor (Ca
Host: Michael A. Levine, MD, FAAP, MACE, FACP Host: B. Michelle Schweiger, DO, MPH Autosomal Dominant Hypocalcemia Type 1 (ADH1) is caused by gain-of-function variants of the CASR gene encoding the calcium-sensing receptor (Ca
Host: Michael A. Levine, MD, FAAP, MACE, FACP Host: B. Michelle Schweiger, DO, MPH Autosomal Dominant Hypocalcemia Type 1 (ADH1) is caused by gain-of-function variants of the CASR gene encoding the calcium-sensing receptor (Ca
Host: Michael A. Levine, MD, FAAP, MACE, FACP Host: B. Michelle Schweiger, DO, MPH Autosomal Dominant Hypocalcemia Type 1 (ADH1) is caused by gain-of-function variants of the CASR gene encoding the calcium-sensing receptor (Ca
Host: Michael A. Levine, MD, FAAP, MACE, FACP Host: B. Michelle Schweiger, DO, MPH Autosomal Dominant Hypocalcemia Type 1 (ADH1) is caused by gain-of-function variants of the CASR gene encoding the calcium-sensing receptor (Ca